Open Access<p>Targeting PIN-1 Attenuates GCB DLBCL Cell Proliferation Through Inhibition of PI3K/AKT Signaling</p>
Author(s) -
Haijun Yang,
Ping Zhang,
Junkuo Li,
Yang Gao,
Luyao Zhao,
Jia Li,
Mei Guo,
Jingfang Zhang,
Haimei Li,
Fuqiang Wang,
Yufen Yuan
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s247429
Subject(s) - pi3k/akt/mtor pathway , protein kinase b , cancer research , diffuse large b cell lymphoma , cell growth , signal transduction , biology , germinal center , lymphoma , medicine , chemistry , b cell , microbiology and biotechnology , immunology , antibody , genetics
Diffuse large B cell lymphoma (DLBCL) is a highly heterogeneous type of non-Hodgkin lymphoma with many molecular subtypes that can be distinguished by gene expression profiling (GEP). However, the pathogenesis of DLBCL is still unclear.